Brand Name | Status | Last Update |
---|---|---|
cisplatin | ANDA | 2024-02-12 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Non-small-cell lung carcinoma | D002289 | — | — | 114 | 330 | 178 | 20 | 33 | 619 |
Head and neck neoplasms | D006258 | — | — | 67 | 166 | 61 | 2 | 19 | 284 |
Neoplasms | D009369 | — | C80 | 148 | 76 | 21 | 1 | 13 | 229 |
Squamous cell carcinoma of head and neck | D000077195 | — | — | 60 | 121 | 46 | 2 | 17 | 225 |
Uterine cervical neoplasms | D002583 | HP_0030159 | — | 40 | 85 | 71 | 1 | 28 | 212 |
Esophageal neoplasms | D004938 | — | C15 | 26 | 109 | 47 | 5 | 19 | 185 |
Urinary bladder neoplasms | D001749 | — | C67 | 30 | 97 | 27 | 2 | 11 | 152 |
Small cell lung carcinoma | D055752 | — | — | 23 | 53 | 28 | 2 | 11 | 107 |
Esophageal squamous cell carcinoma | D000077277 | — | — | 7 | 69 | 28 | 1 | 6 | 105 |
Squamous cell carcinoma | D002294 | — | — | 28 | 58 | 18 | 1 | 4 | 97 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lung neoplasms | D008175 | HP_0100526 | C34.90 | 52 | 133 | 61 | — | 13 | 232 |
Stomach neoplasms | D013274 | EFO_0003897 | C16 | 45 | 125 | 53 | — | 14 | 213 |
Nasopharyngeal neoplasms | D009303 | — | — | 12 | 95 | 74 | — | 18 | 185 |
Nasopharyngeal carcinoma | D000077274 | — | — | 9 | 79 | 75 | — | 17 | 169 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 45 | 65 | 26 | — | 10 | 131 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 26 | 77 | 11 | — | 8 | 108 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 31 | 62 | 7 | — | 2 | 86 |
Cholangiocarcinoma | D018281 | — | C22.1 | 21 | 41 | 15 | — | 4 | 71 |
Biliary tract neoplasms | D001661 | — | C24.9 | 16 | 51 | 11 | — | 2 | 67 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 6 | 34 | 19 | — | 12 | 64 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hearing loss | D034381 | EFO_0004238 | H91.9 | 2 | 5 | — | — | 4 | 10 |
Uterine neoplasms | D014594 | EFO_0003859 | C55 | — | 5 | — | — | 2 | 7 |
Thymus neoplasms | D013953 | — | C37 | 2 | 5 | — | — | — | 6 |
Colonic neoplasms | D003110 | — | C18 | 3 | 4 | — | — | — | 6 |
Penile neoplasms | D010412 | — | C60 | 1 | 5 | — | — | — | 6 |
Brenner tumor | D001948 | — | — | 3 | 1 | — | — | 1 | 5 |
Papillomaviridae | D027383 | — | — | — | 4 | — | — | 1 | 5 |
B-cell lymphoma | D016393 | — | — | 4 | 2 | — | — | — | 5 |
Cystadenocarcinoma | D003536 | — | — | 2 | 1 | — | — | 1 | 4 |
Digestive system neoplasms | D004067 | — | — | 2 | 3 | — | — | — | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Appendiceal neoplasms | D001063 | EFO_0003880 | C18.1 | 2 | — | — | — | 2 | 4 |
Renal insufficiency | D051437 | HP_0000083 | N19 | 1 | — | — | — | 3 | 4 |
Rhabdomyosarcoma | D012208 | — | — | 2 | — | — | — | — | 2 |
Desmoplastic small round cell tumor | D058405 | — | — | 2 | — | — | — | — | 2 |
Hydronephrosis | D006869 | EFO_0005562 | N13.30 | 1 | — | — | — | — | 1 |
Autonomic nervous system diseases | D001342 | EFO_0009532 | G90 | 1 | — | — | — | — | 1 |
Pinealoma | D010871 | — | — | 1 | — | — | — | — | 1 |
Primary myelofibrosis | D055728 | — | D47.4 | 1 | — | — | — | — | 1 |
Medical sociology | D012962 | — | — | 1 | — | — | — | — | 1 |
Neurotoxicity syndromes | D020258 | — | G92 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Circulating neoplastic cells | D009360 | — | — | — | — | — | — | 2 | 2 |
Malnutrition | D044342 | EFO_0008572 | E40-E46 | — | — | — | — | 2 | 2 |
Cervical intraepithelial neoplasia | — | — | D06 | — | — | — | — | 2 | 2 |
Cardiovascular diseases | D002318 | HP_0001626 | — | — | — | — | — | 2 | 2 |
Deglutition disorders | D003680 | HP_0002015 | R13.1 | — | — | — | — | 1 | 1 |
Multiple primary neoplasms | D009378 | — | — | — | — | — | — | 1 | 1 |
Dna damage | D004249 | — | — | — | — | — | — | 1 | 1 |
Double-stranded dna breaks | D053903 | — | — | — | — | — | — | 1 | 1 |
Pregnancy | D011247 | EFO_0002950 | Z33.1 | — | — | — | — | 1 | 1 |
Pleural effusion | D010996 | HP_0002202 | J90 | — | — | — | — | 1 | 1 |
Drug common name | Transplatin |
INN | — |
Description | trans-Dichlorodiammineplatinum(II) is the trans isomer of the coordination complex with the formula trans-PtCl2(NH3)2, sometimes called transplatin. It is a yellow solid with low solubility in water but good solubility in DMF. The existence of two isomers of PtCl2(NH3)2 led Alfred Werner to propose square planar molecular geometry. It belongs to the molecular symmetry point group D2h.
|
Classification | Small molecule |
Drug class | antineoplastics (platinum derivatives) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | 15663-27-1 |
RxCUI | — |
ChEMBL ID | CHEMBL1386 |
ChEBI ID | 27899 |
PubChem CID | 5702198 |
DrugBank | DB00515 |
UNII ID | — |